Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | AKT1 | P31749 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | PTPRB | P23467 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | PTPRA | P18433 | 1/20 | 0.40 |
| ▸ | CTSS | P25774 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2346109 | 1.00 | CA12 (0.44) | CA12CA1CA7CA14RECQL | |
| SCHEMBL2343598 | 0.88 | CA12 (0.45) | CA12CA1CA7CA14RECQL | |
| SCHEMBL2343596 | 0.88 | CA12 (0.45) | CA12CA1CA7CA14RECQL | |
| SCHEMBL2712570 | 0.87 | AKT1 (0.45) | CA12CA1CA7CA14RECQL | |
| Hydrochloric Acid SCHEMBL7429104 | 0.87 | MAPK1 (0.41) | CA12CA1CA7CA14RECQL | |
| SCHEMBL6473387 | 0.85 | MAPT (0.45) | CA12CA1CA7CA14RECQL | |
| SCHEMBL8219589 | 0.85 | MAPT (0.45) | CA12CA1CA7CA14RECQL | |
| SCHEMBL8225007 | 0.84 | MAPT (0.52) | CA12CA1CA7CA14RECQL | |
| SCHEMBL2711160 | 0.83 | CA12 (0.50) | CA12CA1CA7CA14RECQL | |
| SCHEMBL2210445 | 0.82 | CA12 (0.49) | CA12CA1CA7CA14RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8008315-B2 | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | Merck, Sharp & Dohme Corp. (US) | 2011-08-30 | — | — | US | disclosed |
| US-8008315-B2 | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | Merck, Sharp & Dohme Corp. (US) | 2011-08-30 | — | — | US | disclosed |
| US-7829597-B2 | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | Merck, Sharp & Dohme, Inc. (US) | 2010-11-09 | — | — | US | disclosed |
| US-20100210693-A1 | BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Merck, Sharpe & Dohme Corp. | 2010-08-19 | — | — | US | disclosed |
| US-20100210693-A1 | BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Merck, Sharpe & Dohme Corp. | 2010-08-19 | — | — | US | disclosed |
| EP-1673078-B1 | BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK & CO INC (US) | 2008-05-28 | — | — | EP | disclosed |
| US-20060293380-A1 | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | MERCK SHARP & DOHME LLC | 2006-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060293380-A1 | Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease | BACE1, BACE2, PSEN1 | CA12 2807/4885CA1 825/4885CA7 1708/4885 |
| US-20100210693-A1 | BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | BACE1, BACE2, PSEN1 | CA12 2866/4885CA1 843/4885CA7 1940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.